Michelle Robertson, EVP and Chief Financial Officer of Geron Corp ($GERN), sold shares once on the open market in the last 365 days for a total of $19,119. Her most recent sale occurred on February 18, 2026. These sales rank her 11,058th out of 11,678 insiders by value, well below the average of $8.6 million across about 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | GERON CORP | $GERN | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S | Common Stock | 9855 | $1.94 | 17,645.0000 | 667,101,756 | 35.84% | 0.00% |
| Feb. 18, 2026 | GERON CORP | $GERN | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | M | Common Stock | 27500 | $0.00 | 27,500.0000 | 667,101,756 | 9999.99% | 0.00% |
| Feb. 18, 2026 | GERON CORP | $GERN | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 27500 | $0.00 | 82,500.0000 | 667,101,756 | 25.00% | 0.00% |
| Feb. 17, 2026 | GERON CORP | $GERN | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 1660000 | $0.00 | 1,660,000.0000 | 667,101,756 | 9999.99% | 0.25% |
| May 22, 2025 | Verastem, Inc. | $VSTM | ROBERTSON MICHELLE | Director | A | Common Stock | 8333 | $0.00 | 16,666.0000 | 54,173,000 | 100.00% | 0.02% |
| May 22, 2025 | Verastem, Inc. | $VSTM | ROBERTSON MICHELLE | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 54,173,000 | 9999.99% | 0.02% |
| Feb. 18, 2025 | GERON CORP | $GERN | ROBERTSON MICHELLE | EVP, Chief Financial Officer | A | Stock Option (right to buy) | 656000 | $0.00 | 656,000.0000 | 646,033,247 | 9999.99% | 0.10% |
| Feb. 18, 2025 | GERON CORP | $GERN | ROBERTSON MICHELLE | EVP, Chief Financial Officer | A | Restricted Stock Units | 110000 | $0.00 | 110,000.0000 | 646,033,247 | 9999.99% | 0.02% |
| June 18, 2024 | Verastem, Inc. | $VSTM | ROBERTSON MICHELLE | Director | A | Common Stock | 8333 | $0.00 | 8,333.0000 | 26,832,000 | 9999.99% | 0.03% |
| June 18, 2024 | Verastem, Inc. | $VSTM | ROBERTSON MICHELLE | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 26,832,000 | 9999.99% | 0.05% |
| June 6, 2024 | GERON CORP | $GERN | ROBERTSON MICHELLE | EVP, Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 570,645,405 | 9999.99% | 0.04% |
| March 11, 2024 | Verastem, Inc. | $VSTM | ROBERTSON MICHELLE | Director | D | Stock Option (right to buy) | 5291 | $0.00 | 0.0000 | 22,054,000 | 100.00% | 0.02% |
| March 11, 2024 | Verastem, Inc. | $VSTM | ROBERTSON MICHELLE | Director | A | Stock Option (right to buy) | 5291 | $0.00 | 5,291.0000 | 22,054,000 | 9999.99% | 0.02% |
| Feb. 14, 2024 | GERON CORP | $GERN | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | A | Employee Stock Option (Right to Buy) | 850000 | $0.00 | 850,000.0000 | 570,645,405 | 9999.99% | 0.15% |
| Sept. 25, 2023 | GERON CORP | $GERN | ROBERTSON MICHELLE | EVP, Chief Financial Officer | A | Employee Stock Option (right to buy) | 1350000 | $0.00 | 1,350,000.0000 | 380,784,846 | 9999.99% | 0.35% |
| May 11, 2023 | Editas Medicine, Inc. | $EDIT | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S | Common Stock | 949 | $9.87 | 106,610.0000 | 0 | 0.88% | 0.00% |
| March 3, 2023 | Editas Medicine, Inc. | $EDIT | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S | Common Stock | 184 | $8.89 | 107,559.0000 | 0 | 0.17% | 0.00% |
| March 2, 2023 | Editas Medicine, Inc. | $EDIT | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 94500 | $0.00 | 94,500.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2023 | Editas Medicine, Inc. | $EDIT | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | A | Common Stock | 31500 | $0.00 | 107,743.0000 | 0 | 41.32% | 0.00% |
| Feb. 13, 2023 | Editas Medicine, Inc. | $EDIT | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S | Common Stock | 4287 | $9.67 | 76,243.0000 | 0 | 5.32% | 0.00% |
| Jan. 10, 2023 | Editas Medicine, Inc. | $EDIT | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S | Common Stock | 1752 | $8.16 | 80,530.0000 | 0 | 2.13% | 0.00% |